menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics

10 1
03.04.2025
Siemens said the acquisition was "complementary" to its expansion into life sciences and would lift its game in a market needing more medication innovation as populations age.

© Fortune